The blood protein fibrin plays a key role in stopping bleeding, but in certain circumstance it can also contribute to disease. Therein lies the challenge for developing a fibrin-targeting drug.

New research reveals that fibrin, a key component of blood clots, may be the secret culprit behind the devastating neurological and inflammatory aftermath of the virus, including long COVID. From ...

An antibody to the blood-clotting protein fibrin leaves coagulation alone but blocks the ensuing inflammatory cascade. Scientists led by Katerina Akassoglou, Gladstone Institutes, San Francisco, ...

Long COVID has become a significant public health concern, with coagulation and neurological complications arising during acute infection and persisting into the post-acute phase, contributing to ...

Fibrin degradation products (FDP) are substances that remain in your bloodstream after your body dissolves a blood clot. Your fibrinolytic (clot-busting) system manages and regulates clot dissolving.

A group of researchers from the United States discovered that the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the formation of highly inflammatory ...

Researchers have found in a new study that Platelet rich fibrin significantly improves peri-implant hard and soft tissue ...

Fibrin degradation products (FDPs) — also called fibrin split products — are small pieces of protein that stay in your blood when a blood clot dissolves inside your body. Doctors can test for the ...